Related Experiment Videos

[Chronic left heart failure. A focus on the pathogenetic basis of medical treatment]

Marija Kristina Novosel1, Torben H Haghfelt

  • 1Odense Universitetshospital, Kardiologisk Afdeling B, Kardiologisk Forskningsenhed. manov99@student.sdu.dk

Ugeskrift for Laeger
|June 8, 2006
PubMed

Insights

Chronic left heart failure involves progressive cardiac decline. Current pharmacotherapy targets key mechanisms, primarily for systolic dysfunction, with future focus on diastolic dysfunction and evidence-based medicine.

Area of Science:

  • Cardiology
  • Pharmacology
  • Pathophysiology

Context:

  • Chronic left heart failure (CLHF) is characterized by progressive cardiac dysfunction.
  • Pathophysiological mechanisms drive the deterioration of cardiac function over time.
  • Increasing therapeutic options necessitate a comprehensive overview of current treatments.

Purpose:

  • To survey current pharmacotherapies for chronic left heart failure.
  • To highlight evidence-based treatments primarily for systolic dysfunction.
  • To emphasize the need for future focus on diastolic dysfunction and evidence-based medicine integration.

Summary:

  • Current pharmacotherapy for CLHF includes angiotensin-converting enzyme inhibitors, aldosterone antagonists, beta-blockers, digoxin, and diuretics.
  • Treatment evidence is predominantly based on managing systolic dysfunction.
  • Future research and clinical practice should incorporate evidence-based medicine for diastolic dysfunction.

Impact:

  • Provides a timely review of heart failure pharmacotherapy.
  • Guides clinicians in managing systolic dysfunction.
  • Highlights critical areas for advancing heart failure treatment, particularly for diastolic dysfunction.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...